(AP) A panel of respiratory experts has voted in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravence for treating chronic lung disease. A majority of Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback